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Background: Current understanding of the impact that sedative agents have on
neurovascular coupling, cerebral blood flow (CBF) and cerebrovascular response remains
uncertain. One confounding factor regarding the impact of sedative agents is the
depth of sedation, which is often determined at the bedside using clinical examination
scoring systems. Such systems do not objectively account for sedation depth at
the neurovascular level. As the depth of sedation can impact CBF and cerebral
metabolism, the need for objective assessments of sedation depth is key. This is
particularly the case in traumatic brain injury (TBI), where emerging literature suggests
that cerebrovascular dysfunction dominates the burden of physiological dysfunction.
Processed electroencephalogram (EEG) entropy measures are one possible solution
to objectively quantify depth of sedation. Such measures are widely employed within
anesthesia and are easy to employ at the bedside. However, the association between
such EEG measures and cerebrovascular response remains unclear. Thus, to improve
our understanding of the relationship between objectively measured depth of sedation
and cerebrovascular response, we performed a scoping review of the literature.
Methods: A systematically conduced scoping review of the existing literature
on objectively measured sedation depth and CBF/cerebrovascular response was
performed, search multiple databases from inception to November 2020. All
available literature was reviewed to assess the association between objective
sedation depth [as measured through processed electroencephalogram (EEG)] and
CBF/cerebral autoregulation.
Results: A total of 13 articles, 12 on adult humans and 1 on animal models, were
identified. Initiation of sedation was found to decrease processed EEG entropy and
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CBF/cerebrovascular response measures. However, after this initial drop in values there
is a wide range of responses in CBF seen. There were limited statistically reproduceable
associations between processed EEG and CBF/cerebrovascular response. The literature
body remains heterogeneous in both pathological states studied and sedative agent
utilized, limiting the strength of conclusions that can be made.
Conclusions: Conclusions about sedation depth, neurovascular coupling, CBF, and
cerebrovascular response are limited. Much further work is required to outline the impact
of sedation on neurovascular coupling.
Keywords: bispectral index, cerebrovascular autoregulation, cerebrovascular response, depth of sedation,
entropy index
INTRODUCTION
The near ubiquitous use of sedation throughout a variety
of critical care illnesses and its ability to help mediate the
cascading secondary injury pathways in the setting of acute
neurological injuries (1), highlights sedation as an important
aspect of patient care in the intensive care unit (ICU).
Despite the widespread use of sedation, the correlation between
objectively measured depth of sedation, neurovascular coupling
and cerebrovascular response/cerebral blood flow (CBF) is
limited (2–5). To date, most assessments of sedation depth in the
ICU occur using bedside clinical examination scoring systems,
which are confounded by inter- and intra-assessor heterogeneity
(6–8). In addition, such clinical exam scores do not objectively
measure sedation depth at the neurological level but merely
utilize the patient’s response to stimuli as a surrogate for sedation
depth. Moreover, there is still a major concern with overuse
of sedatives as emerging evidence demonstrates an association
between sedative dosing exposure and worse overall 6 month
outcomes (9–12).
In specific critical illnesses, the impact that sedation has
on cerebrovascular response is of paramount interest. Such
is the case in the treatment of moderate/severe traumatic
brain injuries (TBI), where sedation is used for its ability to
reduce cerebral metabolic activity and conserve CBF with the
hopes that it will maintain healthy homeostasis and reduce
secondary injury (13, 14). However, recent comprehensive
reviews evaluating the impact of various commonly utilized
sedative agents in TBI care, and their corresponding impact
on CBF/cerebrovascular response, have demonstrated conflicting
results (3, 4, 15). Studies identified in these reviews failed
to record objectively measured sedation depth, and only
commented on the sedative agent type and dosing. Similarly, two
recent works evaluating continuously measured cerebrovascular
reactivity in TBI patients, in response to fluctuations in sedative
agent doses, found that sedative dose change resulted in little-to-
no impact on cerebrovascular reactivity (5, 16). However, again,
no objective measures of sedation depth were utilized in these
works. Thus, it remains unknown if there is an optimal depth
of sedation in each individual patient which would promote
recovery while preserving neurovascular coupling and a healthy
cerebrovascular state.
Processed electroencephalogram (EEG) is a commonly
utilized technology in the operating room, to objectively
assess sedation depth during anesthesia. Bispectral index (BIS)
monitoring is the most common processed EEGmethod to assess
sedation depth objectively, with the Entropy index monitoring
less prevalent. Both of these indices leverage primarily superficial
EEG signals from the frontal lobe (17, 18). However, BIS and
Entropy Index adoption for routine monitoring in the ICU has
been limited. Furthermore, the association between BIS/Entropy
metrics and CBF/cerebrovascular response is uncertain. Though
recent work from our laboratory suggests there is the presence
of individual patient optimal sedation levels in TBI as measured
through BIS (16), such findings are still preliminary and
exploratory in nature. Thus, if we are to adopt BIS for continuous
assessment of sedation depth in critical and neurocritical care,
we require clarity regarding any link between its metrics,
neurovascular coupling and CBF/cerebrovascular response. As
such, the goal of this study was to perform a systematically
conducted scoping review of the literature, assessing for any
documented association between BIS and CBF/cerebrovascular
reactivity, in humans or animal models.
MATERIALS AND METHODS
A systematically conducted scoping review of the available
literature was conducted using the methodology outlined in the
Cochrane Handbook for Systematic Reviewers (19). The data was
reported in line with the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) (20). Appendix A of
the Supplementary Materials provides the PRISMA checklist.
Search strategy and methodology is similar to other scoping
reviews published by our group (3, 21, 22).
The review questions and search strategy were decided upon
by the supervisor (F.A.Z.) and primary author (L.F.).
Search Question, Population, and Inclusion
and Exclusion Criteria
The question posed for systematic review was: What is
the association between objectively measured depth of
sedation, as assessed with processed EEG (i.e., BIS), and the
CBF/cerebrovascular response? All studies, either prospective or
retrospective, of any size were included. We also included both
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human and animal studies, to be comprehensive in our scoping
overview of the literature.
The primary outcome measure was the association between
processed EEG measures and CBF or the cerebrovascular
responsiveness, as documented by any neuroimaging technique
(i.e., magnetic resonance imaging, computed tomography, PET)
or continuous CBF/cerebrovascular monitoring (i.e., laser-
Doppler flow probe, transcranial Doppler or any other objective
means of CBF determination). Similarly, studies evaluating
BIS and cerebral autoregulation/cerebrovascular reactivity, in
response to sedation administration, we also included. Secondary
outcomes included any other associated physiologic responses to
BIS that were documented.
All studies whether prospective or retrospective, of all sizes,
human subject or animal models, and with the use of processed
EEG (i.e., BIS or Entropy Index) with formal documentation of
cerebrovascular response/CBF were eligible for inclusion in this
review. Exclusion criteria were the following: being non-English,
using non-processed EEG (i.e., not BIS or Entropy Index), or
lacking documentation of the association between processed EEG
metrics and CBF/cerebrovascular response.
Search Strategy
MEDLINE, BIOSIS, EMBASE, Global Health, SCOPUS, and
Cochrane Library from inception to November 2020 were
searched using individualized search strategies for each database.
The search strategy for MEDLINE can be seen in Appendix B
of the Supplementary Materials, with a similar search strategy
used for the other databases. Finally, the reference lists of review
articles on the cerebrovascular/CBF response to sedation were
examined to ensure no references were left out.
Study Selection
Using 2 reviewers (LF and JD), a 2-step review of all articles
returned by our search strategies was performed. First, the
reviewers independently screened all titles and abstracts of the
returned articles to decide whether they met the inclusion
criteria. Second, full text of the chosen articles was assessed to
confirm whether they met the inclusion criteria and that the
primary outcome of documented association between processed
EEG and CBF/cerebrovascular response. Any discrepancies
between the 2 reviewers were resolved by a third party (FZ).
Data Collection
Data was extracted from the selected articles and stored in
multiple electronic databases to ensure data integrity.
Human Studies
Data fields included the following: number of patients, study
type, mean age, patient characteristics, goal of the study, sedation
dose and duration, technique to measure CBF/cerebrovascular
assessment, CBF/cerebrovascular response, other outcomes
and conclusion (i.e., regarding association between BIS and
CBF/cerebrovascular response).
Animal Studies
Data fields included the following: type of models and model
characteristics, goal of the study, sedation dose, technique to
measure CBF/cerebrovascular assessment, CBF/cerebrovascular
response, other outcomes, and conclusion (i.e., regarding
association between BIS and CBF/cerebrovascular response).
Bias Assessment
Given the goal of this review was to provide a comprehensive
scoping overview of the available literature, a formal bias
assessment was not conducted.
Statistical Analysis
A meta-analysis was not performed in this study because of the
heterogeneity of study designs and data.
RESULTS
Search Results and Study Characteristics
The results of the search strategy across all databases and other
sources are summarized in Figure 1. Overall, a total of 8,707
articles were identified from the databases searched. A total of
2,747 articles were removed because of duplicated references,
leaving 5,960 to review. By applying the inclusion/exclusion
criteria to the title and abstract of these articles, we identified
72 articles that fit these criteria. Three articles were added from
reference sections of pertinent review articles, leaving a total of 75
full papers to review. On applying the inclusion/exclusion criteria
to the full-text documents, only 13 articles were found eligible
for inclusion in the systematic review. Articles were excluded
because they either did not report details around the association
between processed EEG and CBF/cerebrovascular response, were
review articles, or were non-relevant. Twelve articles described
human adult patients, and the other 1 used animal models. All
were original studies, with none describing patients under the age
of 18.
Tables 1, 2 show the 12 articles that had human patients
and documented the association between processed EEG and
CBF/cerebrovascular response (23–34). All articles used the BIS
methodology, except for one which used the Entropy Index (23).
Patients were either under deep sedation or varying levels of
sedation (23, 26, 27), or sleeping (in one study) (24). In order
to characterize CBF and vasculature response, the following
techniques were used: Positron Emission Tomography (PET)
(23, 24, 26–28), transcranial Doppler (25, 31–34) and laser
Doppler flowmetry (29, 30). In the human studies, the following
cohorts were studied: 7 studies used healthy patients (23–
28, 34), two used patients undergoing a craniotomy (29, 30),
one used TBI patients (31), one used patients with spinal or
maxillofacial disorders (32), and one used patients undergoing
carotid endarterectomy (33). The majority of these studies
controlled partial carbon dioxide pressure (PCO2) through
mechanical ventilation (29, 30).Appendix C shows the study that
used deeply sedated animal models with BIS recording (35). The
animal model study failed to comment on PCO2 (35).
BIS Human CBF Response
Overall there was limited direct correlation with BIS and CBF
or cerebral blood flow velocity (CBFv), with many studies either
demonstrating no correlation (26, 27, 29, 30) or a wide variation
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FIGURE 1 | PRISMA Flow Diagram. PRISMA, Preferred Reporting In Systematic Reviews and Meta-Analysis.
in response (24, 25, 28, 34). One study demonstrated BIS
having a linear correlation with CBFv and propofol (34), though
the variation in CBFv response was significant. Furthermore,
in situations where consciousness was measured throughout
the awake and sedated states, there was a consistent initial
decrease in both BIS and CBF/CBFv from the conscious to
unconscious state, with sevoflurane (26), propofol (28, 31, 32),
or midazolam (25). However, after this initial drop in BIS and
CBF/CBFv, there was a wide variation in CBF/CBFv response
to similar BIS levels across the population. Of note, one study
used midazolam as the initial agent to induce sedation after
which flumazenil was used to reverse the sedative effects of
midazolam, this increased BIS but did not change CBFv (25).
Many of these studies measured various states of consciousness,
as evaluated by different levels of BIS, with all having a
wide individual variation in CBF/CBFv response at each level
(26, 28, 29, 32, 34).
Within the study that evaluated the relationship between
CBF and sleep stages, there was a linear correlation between
regional CBF and BIS (24). Finally, in a single study that
used cross clamping of the carotid artery to modify blood
flow, a strong positive correlation between BIS and CBFv was
found (33).
BIS Correlation With Cerebral Vessels and
Regional Responses
Only two studies evaluated the capillary venous blood flow
response (the blood flow assessed through the capillary bed of the
brain) through the use of a laser Doppler flow and spectroscopy.
Both studies found that there was limited connection with BIS
and cerebrovascular response (29, 30). Three drugs were used
to achieve BIS levels of 50 and 21; sevoflurane (29), propofol
(30) and remifentanil (30). With each agent there was varying
change in blood flow. However, propofol did have a significant
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TABLE 1 | Human included studies–general characteristics and study goals.
References No.
patients
study type Mean age (y) Patient characteristics Primary and secondary goal of study
Healthy patients
Maksimow et al. (23) 16 Prospective study 20–30 Healthy male volunteers Primary: Evaluate the correlation between EEG
Entropy and rCBF
Noirhomme et al. (24) 6 Prospective study 20–30 Healthy male volunteers Primary: Assess the correlation between BIS
and rCBF
Ogawa et al. (25) 16 Prospective study 20–26 Healthy young males Primary: Assess the cerebral circulatory effects
of flumazenil after midazolam sedation
Schlünzen et al. (26) 9 Prospective study 21–25 Healthy volunteers Primary: Evaluate the rCBF effect of
sevoflurane Secondary: Differences for
sub-anesthesia and anesthesia dose
Schlünzen et al. (27) 9 Prospective study Not mentioned Healthy volunteers Primary: Evaluate the dose-dependent effects
of isoflurane on CBF
Veselis et.al. (28) 10 Prospective study 35 ± 10 Healthy male volunteers Primary: Assess the effects of thiopental and
propofol on regions of the brain
Craniectomy
Klein et al. (29, 30) 20 Prospective study Not mentioned Patients undergoing a
craniotomy
Primary: Assess the effect sevoflurane induced
BIS reduction on cerebral microcirculation
Klein et al. (29, 30) 21 Prospective study 35–61 Patients undergoing a
craniotomy
Primary: Effect of cerebral microcirculation
during propofol infusion
Head injury
Skytioti et al. (31) 17 Prospective study 23–76 ASA physical status of I or II Primary: ICA flow response to anesthesia,
pneumoperitoneum and head-up tilt
Other adult surgery populations
Conti et al. (32) 40 Prospective study 18–65 Patients undergoing
treatment for spinal or
maxillofacial disorders
Primary: Effect of cerebral hemodynamics after
propofol-remifentanil or sevoflurane infusions
Dahaba et al. (33) 20 Prospective study 62.2 ± 9.7 Patients undergoing carotid
Endarterectomy
Primary: Detection of CBFv using BIS
Ludbrook et al. (34) 7 Prospective study 18–50 Healthy subjects undergoing
elective orthopedic surgery
Primary: Evaluate the effects of Propofol on the
Brain
ASA, American society of anesthesiologist; BIS, bispectral index; CBF, cerebral blood flow; CBFv, cerebral blood flow velocity; CPP, cerebral perfusion pressure; EEG,
electroencephalogram; ICA, internal carotid artery; rCBF, regional cerebral blood flow; TBI, traumatic brain injury.
increase in regional oxygen saturation by 20% (30). Sevoflurane
at high doses (over 0.7%) caused significant decrease to CBF of
cerebellum at over 18%, asmeasured through PET (26). Similarly,
in the cortical areas there was a distinct decrease in CBF with
a large dose of sevoflurane (over 0.7%) and propofol (over 12.5
ug/ml) (23).
Entropy Index Human CBF Response
In the single study that used the Entropy Index to assess depth
of sedation, there was a wide variation in CBFv response (23).
Within this study there were examples of the Entropy Index
having a linear correlation with CBFv, during sevoflurane or
propofol-remifentanil infusions, when the patient transitioned
from awake to sedated states.
Animal Models
The single animal study used pigs with systemic arterial
hypotension and liver trauma. This study found a slight
positive correlation between CBFv and BIS, though this
lacked statistical significance (35). Coupled with this,
BIS was also linked with cerebral tissue oxygenation
as measured through near infrared spectroscopy within
these models.
DISCUSSION
Though the literature lacked consistent significant correlations
between processed EEG/depth of sedation and cerebrovascular
response/CBF, they are undoubtedly associated. This was
depicted in all studies that measured BIS or Entropy Index
values and CBF/CBFv response, from a conscious to unconscious
state. Such studies found that all sedatives caused a decrease
in processed EEG values and CBF/CBFv, while mean arterial
pressure (MAP) was maintained (23, 25, 26, 28, 31, 32).
Furthermore in the one study that clamped the carotid arteries,
they found BIS to be correlated with a decrease in CBFv
caused through the clamping (33). Though these are limited
connections, it highlights that there exists some correlation
between objectively measured sedation depth using processed
EEG, neurovascular coupling and CBF.





































TABLE 2 | Human treatment and cerebrovascular response–study details.




Cerebrovascular response Other outcome Conclusions
Healthy patients






Not mentioned • rCBF: PET
• Depth of Sedation: EEG
Entropy Index
• Both drugs initially decreased BIS and
rCBF though after the initial decrease
(∼5 ml/100 g/min) there was a wide
range in BIS and rCBF response
• Heavy sedation indicated by BIS did
correlate with the lowest rCBF values
• PCO2 maintained through ventilation





Despite the EEG and rCBF
correlation at the extreme end of
the spectrum there is a vast
amount of internal variations
Noirhomme et al. (24) Sleep stages • rCBF: PET
• Depth of Sedation: BIS
Linear correlation with rCBF and BIS of up
to 0.57 were found at various sleep
stages, however BIS values varied widely
in both sleep stages and CBF levels
Though the level of rCBF and
BIS correlated, there was
massive variance within BIS
response to sleep stages









2H • CBFv: Transcranial Doppler
• ETCO2: Pulse oximeter
• Depth of Sedation: BIS
4 channel
• For both sedation, BIS and CBFv
decreased from baseline values (68 to
64 ± 13 cm/s) with limited change to
ETCO2
• Despite the increase in BIS level after
Flumazenil infusion CBFv still decreased
both alone and after midazolam to 61 ±
11 cm/s
Flumazenil reversed the
BIS drop of Midazolam
without effecting CBFv
Despite the fluctuation in BIS,
CBFv remained reduced after
sedation, this indicates limited
correlation between these values
Schlünzen et al. (26) Sevoflurane at 0.4,
0.7, and 2%
Not mentioned • rCBF: PET
• Depth of Sedation: BIS
• Sevoflurane decreased the BIS values
dose dependently from (96.8 to 38.5 ±
5)
• No significant change in global CBF was
observed
• rCBF increased in the anterior cingulate
(17–21%) and decreased in the
cerebellum (18–35%), this was identified
at all three levels of sedation compared
to baseline
• PCO2 maintained through ventilation
At sevoflurane concentrations at
0.7% and 2.0% a significant
decrease in rCBF with
dose-dependent decreases to
BIS
Schlünzen et al. (27) Isoflurane: 0.2,
0.4, and 1 MAC
Not mentioned • rCBF: PET
• Depth of Sedation: BIS
• Dose-dependent decrease to BIS (from
96 to 34 ± 6) with Isoflurane infusion
but no significant change to global CBF
seen
• rCBF increased in anterior cingulate and
decreased in the cerebellum
• PCO2 maintained through ventilation
Little correlation with BIS and
global CBF




2H • rCBF: SPM 99 analysis of PET
• Depth of Sedation: BIS
• Oxygenation: pulse oximeter
• BIS decreased similar in both sedations,
however limited change to rCBF
• PCO2 maintained through ventilation
Hypnosis drastically
reduced BIS level to 70
There is no clear correlation
























































































TABLE 2 | Continued




Cerebrovascular response Other outcome Conclusions
Craniectomy
Klein et al. (29, 30) Sevoflurane
1.5–2.5% vol/vol
Not mentioned • Capillary venous blood flow
and rSO2: Laser-Doppler
flowmetry and spectroscopy
• Depth of Sedation: BIS
Limited fluctuation from BIS levels of










Not mentioned • Capillary venous blood flow
and rSO2: Laser-Doppler
flowmetry and spectroscopy
• Depth of Sedation: BIS
• The reduction of BIS from 40 to 21 in
both groups had limited results to
capillary venous blood flow but propofol
had a 20% increase in rSO2
Changes in BIS do not seem to
influence regional capillary blood
flow
Head injury
Skytioti et al. (31) Propofol: 5.8 to
7.9 mg/kg/h
Not mentioned • CBFv: Transcranial Doppler
Ultrasound
• Depth of Sedation: BIS
• ETCO2: Breath samples
• MAP: Finapres
• CBFv and BIS decreased with the
introduction of propofol (∼100 ml/min)
and remained low in both after
pneumoperitoneum and head up tilt at
200 ml/min
• PCO2 maintained through ventilation
Limited correlation from BIS to
CBFv as the true measured EEG
effects were not commented on
Other adult surgery populations




BIS values of 50
and 35
Not mentioned • CBFv: Transcranial Doppler
• Depth of Sedation: BIS
• THRR: Calculated from
blood flow
• At BIS level of 50 both drugs decreased
CBFv (over −10 cm/s) however at BIS
35 sevoflurane saw a slight increase,
though this was still less then awake (p
< 0.05)
• Sevoflurane BIS value of 35 had a
decrease in THRR to 1.1,
propofol-remifentanil had a slight
increase to 1.3 baseline was 1.2
• PCO2 maintained through ventilation









Sevoflurane had differing effect
on cerebral autoregulation at
different concentrations
Despite the BIS and CBFv
coupling it is still unclear if this
decrease in CBFv is associated
with EEG or rather the drug’s
influence on cerebral circulation






Not mentioned • CBFv: Transcranial doppler
• Depth of Sedation: BIS
• MAP: Controlled
with vasopressin
• There was a correlation between BIS
and CBFv with a higher correlation after
cross clamping of the carotid artery on
either side (p = 0.112)
• Good correlation (r=0.763) between
ipsilateral BIS-Vista and CBFv
• BIS-Vista decline with CBFv decline
both 40%
• PCO2 maintained through ventilation
• BIS and CBFv had a
measurable correlation
responsive to lateral influence
on the blood flow
• BIS-Vista had a discriminative
power of depicting a CBFv
decline however it cannot be
considered a reliable indicator
of
cerebral ischemia/hypoperfusion.




25Min • MAP and blood samples:
Arterial catheter
• CBFv: Transcranial Doppler
• Depth of sedation: BIS
• Propofol rapidly dropped BIS after
6.5min which correlated with low CBFv
at 60% of baseline however BIS did
carry heavy patient variation
• PCO2 maintained through ventilation
MAP also had a
significant drop at
6.5min
Propofol and BIS had close
relationship together but limited
correlation to CBFv
BIS, bispectral index; CA, cerebral autoregulation; CBF, cerebral blood flow; CBFv, cerebral blood flow velocity; CMRO2, cerebral metabolic rate of oxygen; EEG, electroencephalogram; ETCO2, end tidal carbon dioxide; MAP, mean
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FIGURE 2 | Theoretical Autoregulation curve for Normal, Heavily Sedated, and
Metabolically Suppressed Patients. The figure shows three therotical
autoregulatory curves for three patient types: normal, heavily sedated and
metabolically supressed. a.u., arbitray units; CBF, cerebral blood flow; LLA,
lower limit of autoregulation; MAP, mean arterial blood pressure; ml/100
gm/min, milliliter per 100 grams per minute; mmHg, millimeters of mercury;
ULA, upper limit of autoregulation.
Within this review, depth of sedation (as measure through
BIS or Entropy Index) failed to be clearly linearly associated
with CBF. However, this should not be a surprise given CBF is
under the control of the innate cerebral autoregulatory function
of the pre-capillary arterioles (36). CBF has been shown to
follow an S-shaped curve in association with changes in systemic
arterial blood pressure, allowing for maintenance of CBF during
wide fluctuations of blood pressure. Yet, beyond certain points
in MAP, CBF becomes pressure passive. Thus, with escalating
sedative doses, corresponding to changes in BIS, there is the
potential that we could alter the autoregulatory curve for a
given patient, leading to a non-linear relationship between
CBF and sedation depth. The influence of sedation on cerebral
autoregulation has been demonstrated in past studies (37, 38),
and we have illustrated some theoretical responses to sedation
in Figure 2. In general, with the introduction of sedation, one
would expect lower overall MAP and CBF levels, this would
in turn indicate that the plateau of the Lassen curve would be
lower than an awake patient. Furthermore, the lower limit of
autoregulation would be reduced (emerge at a lower MAP) due
to a less exhausted vasodilatory reserve caused through a decrease
in metabolic demand (39), with the upper limit of autoregulation
being more susceptible to metabolically demanding changes in
MAP. There are presumed instances of metabolic suppression
where the Lassen curve is greatly deteriorated and thus the lower
and upper limits of autoregulation are significantly deranged
(40). In such cases, the plateau wave would be greatly reduced
or even absent.
This concept is further supported by recent work from
our group, that continuously assessed BIS and cerebrovascular
reactivity (using the pressure reactivity index) in high-frequency
in TBI patients (16). This exploratory work found that there
is a parabolic distribution between BIS and cerebrovascular
reactivity, which is patient specific (see Figure 3 for example).
We were able to demonstrate deterioration in cerebrovascular
reactivity during both light sedation and heavy sedation
(i.e., near burst suppression levels) states. Further, these
findings in theory could lead to targeted sedation to optimize
cerebral autoregulation and reduce secondary insult (16). This
is in corollary to such advances seen with individualized
optimal cerebral perfusion pressure physiologic targets using
cerebrovascular reactivity (41, 42). In this way BIS could be
coupled with other forms of cerebral autoregulatory treatment
methods to achieve cerebral homeostasis, thus highlighting the
impact that processed EEGmetric may play in TBI. Furthermore,
aside from TBI care, such optimized sedation targets in other
critical illnesses may lead to improved cognitive outcomes
in general critical care populations though this has yet to
be explored.
However, the relationship between objective depth of sedation
and CBF or cerebrovascular reactivity is not that simple. This
review highlights a vast heterogeneity within the sedative agent
used and, as the previous discrepancy of the literate illustrates,
each agent may play a different role in cerebral response (3, 4).
Thus the limited BIS and CBF connection demonstrated in this
heterogeneous body of literature, could be related to disparities
in medication type utilized. This was affirmed by the different
cerebral responses seen in studies that used two sedative agents to
achieve similar BIS values (23, 28, 30). Therefore, the full extent
that each sedative agent has on BIS, neurovascular coupling, and
CBF/cerebrovascular reactivity is still largely unknown, requiring
further investigation.
Limitations
First, the literature uncovered was very heterogeneous in design,
and results had a limited cross-sectional relationship based
on the variation of sedative agent used. Second, most studies
focused on small patient populations, with limited ability to
extrapolate findings. Third, different CBF and cerebral vessel
response methods were utilized, which further limits the ability
to compare between studies, populations and extrapolate beyond
the works identified in this review. Fourth, the disparity in
response seen in CBF to changes in processed EEGmetrics limits
our ability to confidently state the correlation between processed
EEG and CBF, highlighting the need for further investigation
in this area. Fifth, most studies focused on low-resolution
physiology data, in assessing the relationship between processed
EEG and CBF/cerebrovascular reactivity. Such data is limited in
its ability to explore the temporal profile of objective sedation
depth changes, using BIS, and CBF/cerebrovascular response.
This highlights the need for continuous high-fidelity data sets,
with BIS and multi-modal cerebral physiologic monitoring to
properly comment on any associations.
Future Directions
Despite the identified limitations of our review and the
knowledge gap in the literature, there are essential avenues
for future investigation highlighted by this work. First, metrics
that focus on processed EEG like BIS or Entropy Index, use
targeted algorithms to reduce the highly variable and vastly
complex EEG output of the superficial area of the frontal
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FIGURE 3 | Example of Optimal Depth of Sedation Based on BIS and PRx. (A) shows the error bar plot for ICP vs. CPP, (B) shows the error bar plot of MAP vs. BIS,
(C) shows the error bar plot of PRx and different BIS values and demostrates the parabolic relationship between BIS and PRx. a.u., arbitray units; BIS, bisprectal
index; CPP, cerebral perfusion pressure; ICP, intracraintal pressure; MAP, mean arterial pressure; mmHg, millimeters of mercury; PRx, pressure reactivity index.
lobe. Thus, if these metrics are implemented to help evaluate
CBF or autoregulation the clinician must be aware that any
change to the normal electrical impedance of the fontal cortex
or the areas of interest are elsewhere, the results would
have impeded accuracy. Therefore, studies will require high-
frequency data streams of processed EEG metrics, linked with
multi-modal cerebral physiologic monitoring to expose the
more consistent physiological response and reduce confounding
factors. Spatial resolution on EEG entropy index assessments
could be improved with large EEG arrays, with signals process for
each channel. Similarly, as PRx is derived from a focal pressure
monitoring, future improvements in spatial resolution for
autoregulation assessments may be facilitated by multi-channel
functional near infrared spectroscopy or bilateral transcranial
Doppler assessments.
The analysis of these continuous variables in conjunction with
processed EEG, will allow the researcher to comment on the
multiple factors that influence BIS like MAP, severe cerebral
ischemia, impaired autoregulation and PCO2. Along with this,
devices like near infrared spectroscopy or parenchymal brain
tissue oxygen probes would both potentially offer both the
assessment of regional cerebral oxygen delivery, in concert with
sedation depth and cerebral autoregulation.
Additionally, multi-modal cerebral physiologic data linked
with medication dosing information in time-series would also
aid in the understanding of various sedative agents and
their subsequent impact on physiology and BIS. As well, by
pairing the dosing regimen the researcher can account for the
influence of other confounding factors in these agents like
MAP or the metabolic coupling effect. Furthermore, targeted
sedation strategies using propofol or barbiturates that have
similar effects globally throughout the brain (3, 43) would
better isolate discrepancy between BIS response and outside
confounding factors.
Finally, when assessing the parabolic relationship between BIS
and PRx, the use of time connected high frequency physiological
data would provide better insight as to the true impairment
of the Lassen curve and optimal BIS values. Current literature
assessing cerebral autoregulation and metabolic suppression
is limited, and is hampered by global assumption about BIS
response and sedation. Factors like subdural hemorrhage causing
fluctuations to regional electrical impedance, ischemia/systemic
vasopressors/blood gas levels causing metabolic fluctuations or
other systemic stimuli triggering increase brain activity, all result
in derangements to BIS values. Thus, continuous data sets
would allow the analysis of separate physiological responses and
patient states throughout treatment. Opening the opportunity
to comment on the interconnected nature of processed EEG to
other cerebral states.
All of this information will need large multi-center data
sets with, studying a variety of critical illness states, healthy
patients undergoing elective surgery, and awake volunteers.
Such comprehensive data collection strategies will highlight
the relationships between sedation depth and cerebrovascular
response. The findings here will better delineate the role of
processed EEG in routine monitoring for patients with critical
illness and potentially the role of individualized sedation metrics
to advance personalizedmedicine approaches in critical care (16).
Such work is the focus of our lab, the Winnipeg Acute TBI
Laboratories, and various research collaboratives (16, 44–47).
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CONCLUSIONS
This review highlights the potential for processed EEG metrics
to provide information regarding CBF/cerebrovascular response.
The literature demonstrates that initiation of sedation will
decrease BIS/Entropy Index, CBF and CBFv, highlighting
processed EEG’s potential to quantify neurovascular coupling.
However, after this initial decrease there is a wide range of
response between BIS and CBF/CBFv seen, both within and
between patient cohorts. Thus, any conclusion about sedation
and its role on neurovascular coupling and cerebrovascular
response is uncertain. Variation in responses may be related
to the differential effects of sedative agents on individual
subject’s autoregulatory function and/or patient’s depth of
sedation. Future research with high frequency datasets is
required to evaluate processed EEG/BIS and its correlation with
CBF/cerebral autoregulation.
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